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Abstract 
Objective: To determine the effect of scaling and root planning treatment on levels of hs-CRP 
(C-reactive protein) in patients with risk of cardiovascular disease. Material and Methods: This 
research is an experimental research with one group pre- and post-test design. This research was 
performed to the periodontal patients who came to the clinic and have risk of cardiovascular 
disease. Medical evaluations included measurement of blood pressure and body mass index were 
performed. Blood samples were obtained from each subject after over night fasting, high-
sensitivity C-reactive protein was measured as an index of inflammation. Blood samples were 
analysed two times before treatment (scaling and root planning) and three weeks later. Statistical 
analysis used Paired t-test. The level of significance was set at 5%. Results: Means-CRP levels 
before and after treatment in scaling and root planning were 3.16 ± 2.37 and 2.18±1.56 
(p=0.007). Conclusion: There are significant differences between hs-CRP levels before and after 
treatment. 
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Introduction 
In developed countries, cardiovascular diseases cause 50% of deaths while in developing 
countries account for 16% of deaths [1]. Cardiovascular disease can be defined as a disease that 
affects the heart or blood vessels by causing a disturbance of blood circulation [1,2]. Atherosclerosis 
is an inflammatory disease caused by a series of specific molecular and specific responses to an injury. 
High levels of plasma cholesterol, especially Low Density Lipoprotein (LDL) are the main risk 
factors that are always associated with the accumulation of plaque on artery walls [3]. 
Atherosclerosis is a multifactorial disease that is the most common cause of coronary heart 
disease. It occurs as a result of complex genetic sets and environmental factors [4,5]. In addition, 
there are new predictors that also participate plays a role in the pathogenesis of cardiovascular 
disease. These include chronic infection or chronic activation of inflammatory processes such as 
chronic abnormalities of the oral cavity and teeth, especially periodontal inflammation [1]. 
Periodontitis is caused by bacteria in dental plaque. Actinobacillus actinomytemcomitans, 
Porphyromonas gingivalis, Prevotella intermedia, Bacteroides forsythus, are the gram negative 
bacteria most commonly associated with periodontitis, and gram-positive bacteria, eg 
Peptostreptococcus micros and Streptococcus intermedius. Bacteria and their products that lead to 
progressive destruction of the periodontal ligament and alveolar bone [1,4,6,7]. In order to cause 
damage, the bacteria must (1) colonize the gingival sulcus by attacking the host defense, (2) damage 
the epithelial crevicular barrier, or, (3) producing substances that may cause tissue damage either 
directly or indirectly [8,9]. 
Epidemiological studies were found that local infections of periodontal disease can cause 
inflammatory mediatorial disorders in systemic disease resulting in atherosclerosis. The occurrence 
of cardiovascular disease is characterized by an increase in C-reactive protein (CRP), and soluble 
cellular adhesion, which leads to cellular response and cellular damage [3,9,10]. 
One of the periodontal disease treatments is scaling and root planing, periodontal therapy 
aimed to inhibit P. gingivalis to maintain CRP level [6]. Periodontal disease as an infection will 
stimulate the liver and produce CRP, which is one of the markers of inflammatory reaction of the 
body, then there will be deposition on the surface of the injured local blood vessels. C-reactive 
protein will bind to the damaged cells and have an effect on complement and activate phagocytes. 
Acute phases of proteins, such as C-reactive protein (CRP) and fibrinogen, affect coagulation, platelet 
activation, and aggregation, contribute to the formation of ateroma [6,11]. 
Significantly elevated CRP levels have been demonstrated in patients with chronic 
periodontitis. One study showed that CRP levels were highest in patients infected with periodontal 
pathogens. CRP is also an in-dependent risk factor for heart disease [1,6,11]. The aim of this study 
is to determine the effect ofscaling and root planning treatment on levels of hs-CRP in patients with 
risk of cardiovascular disease. 
 
Material and Methods 
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Study Design 
This research is an experimental research with one group pre- and post-test design. This 
research was performed to the periodontal patients who came to the clinic and have risk of 
cardiovascular disease.  Subjects must fulfill the inclusion criteria: 1) Patients age between 30-65; 2) 
Patients with moderate to poor oral hygiene, 3) Patients with Body Mass Index (BMI) ≥25kg/m2 
and 4) Patients who are willing to follow the entire series of studies. 
Medical evaluations included measurement of blood pressure and body mass index were 
performed. Classification of blood pressure for adults systolic blood pressure / diastolic blood 
pressure (mmHg); 120/80 normal; 120-139 / 80-89 pre-hypertension; 140-159 / 90-99 hypertension 
stage 1; ≥160 / ≥100 hypertension stage 2. For subject’s Body Mass Index was grouped as: 25.0-
29.9 overweight / at risk; 30.0-34.9 obesity grade 1; 35.0-39.9 obesity grade II; ≥40.0 obesity grade 
III. 
Dental record was taken included assessment of debris and calculus index to get value of oral 
hygiene index-simplified (OHI-S): 0-1.2 good; 1.3-3.0 moderate and 3.1-6 poor.  
Blood samples were obtained from each subject after overnight fasting, high-sensitivity C-reactive 
protein was measured as an index of inflammation. Blood samples were analysed two times before 
treatment (scaling and root planning) and three weeks later after scaling and root planning. 
  
Statistical Analysis 
The data obtained were processed using IBM SPSS Statistics for Windows Software, version 
20 (IBM Corp., Armonk, NY, USA) by using paired t-test. The level of significance was set at 5%. 
 
Ethical Aspects 
This research has received permission from the ethical commission of health research 
Hasanuddin University. Written informed consent was obtained from each subject. 
 
Results 
A total of 30 patients were included in the study. Among them, 19 were males (63.3%) and 
53.3% had 46-55 years old. 93.3% had moderate oral hygiene status, and 43.3% had obesity grade 1. 
33% had hypertension (Table 1). 
Mean hs-CRP values before and after treatment based on age were highest 4.9 ± 2.89 in the 
56-65 year age group and the lowest in the 36-45 years age group were 1.88 ± 1.16. The mean hs-
CRP level was the highest after treatment in the 36-45 year age group of 2.33 ± 2.71 and the lowest 
in the 25-35 year age group of 2.01 ± 1.4. By sex, women's hs-CRP levels both before and after 
treatment were higher than in men. Based on oral hygiene status, mean hs-CRP levels before and 
after treatment moderate oral hygiene was 3.23 ± 2.44 and 2.15 ± 1.6. Poor oral hygiene before and 
after treatment were 2.21 ± 0.66 and 2.5 ± 1.34. In Body Mass Index (BMI) category, patients with 
obesity grade 2 had the highest levels of hs-CRP before and after treatment but decreased. 
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Hypertensive patients had the highest levels of hs-CRP both before and after treatment compared to 
other groups (Table 2). 
 
Table 1. Characteristics samples based on sex, age, oral hygiene, body mass index 
and blood pressure. 
Variables N % 
Sex   
Male  19 63.3 
Female 11 36.7 
Age (in Years)   
26-35 3 10.0 
36-45 5 16.7 
46-55 16 53.3 
56-65 6 20.0 
OHI-S   
Moderate 28 93.3 
Poor  2 6.7 
Body Mass Index (BMI)   
At Risk 8 26.7 
Obesity Grade I 13 43.3 
Obesity Grade II 9 30.0 
Blood Pressure   
Normal 5 17.0 
Pre Hypertension 15 50.0 
Hypertension 10 33.0 
 
 
Table 2. The mean values of hs-CRP before and after treatment. 
    
N 
Mean ± SD hs-CRP Value 
Variables Categories Pre Post 
Sex  Male 19 2.65 ± 2.14 1.61 ± 0.89 
 Female 10 4.13 ± 2.59 3.26 ± 2.01 
Age (in Years) 26-35 3 3.36 ± 3.84 2.01 ± 1.4 
 36-45 5 1.88 ± 1.16 2.33 ± 2.71 
 46-55 15 2.86 ± 1.94 2.14 ± 1.27 
 56-65 6 4.9 ± 2.89 2.21 ± 1.57 
OHI-S Moderate 27 3.23 ± 2.44 2.15 ± 1.6 
 Poor 2 2.21 ± 0.66 2.5 ± 1.34 
Body Mass Index (BMI) At Risk 8 2.96 ± 2.31 1.66 ± 1.05 
 Obesity Grade I 13 2.64 ± 1.45 2.37 ± 1.78 
 Obesity Grade II 8 4.21 ± 3.42 2.4 ± 1.7 
Blood Pressure Normal 5 1.49 ± 1.45 1.31 ± 0.98 
 Pre Hypertension 15 3.50 ± 2.11 2.34 ± 1.73 
 Hypertension 10 3. 53 ± 2.95 2.39 ± 1.52 
 
Mean of hs-CRP before treatment was 3.16 ± 2.37 and after treatment was 2.18 ± 1.56 
indicating 31% level. There was a significant difference between hs-CRP levels before and after 
treatment (p = 0.007). 
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Table 3. Differences in hs-CRP values before and after treatment. 
hs-CRP N Mean ± SD % (Decrease) p-value 
Pre Treatment 29 3.16 ± 2.37 31.0 0.007 
Post Treatment 29 2.18 ± 1.56   
 
Discussion 
Periodontitis is a disease that attacks periodontal tissue, caused by microorganism infection 
in the oral cavity [4]. Epidemiological studies have established that periodontitis is a risk factor for 
cardiovascular diseases [12]. The prevalence of cardiovascular diseases in patients with periodontitis 
is 25 50% higher than in healthy individuals [12]. Poor self-reported oral health (as a possible risk 
factor for periodontitis) and tooth loss (as a possible consequence of periodontitis) are positively 
associated with a coronary atherosclerotic burden [12]. 
An association between oral health and cardiovascular disease has been proposed for more 
than a century. Recently, the possible links between periodontitis and atherosclerosis have intensified 
and are being investigated for possible association and causality. Common risk factors for these 
diseases include increasing age, smoking, alcohol abuse, ethnicity, educational and socioeconomic 
status, being male, diabetes mellitus, and obesity [12,13]. 
P. gingivalis as one of the bacteria that causes periodontitis that produces endotoxin and 
triggers an immune response. The entry of bacteria or bacterial products into the circulation and 
endothelial tissue, where P. gingivalis is able to replicate in endothelial cells, alter the integrity of 
endothelial cells, and have a mechanism of persistence and development within vascular endothelial 
cells resulting in increased effects of expression of the media systemic inflammation [2,4,6,14]. 
Based on Periodontal disease as an infection will stimulate the liver and produce CRP, which 
is one of the markers of inflammatory reaction of the body, then there will be deposition on the 
surface of the local vein [6,11]. CRP belongs to the highly conservative pentraxin family of proteins 
significant to the innate immune reaction. CRP is bound to apoptotic cells, oxidized low-density 
lipoprotein (ox- LDL) and oxidized phospholipids, but do not bind to native low-density lipoprotein. 
It is assumed that CRP is involved in modulation of developing atherosclerosis, because CRP and ox-
LDL are present in atherosclerotic lesions. Slightly enhanced concentrations of CRP may predict 
coronary disease [12,15,16]. 
Significantly elevated CRP levels have been demonstrated in patients with chronic 
periodontitis. One study showed that CRP levels were highest in patients infected with periodontal 
pathogens. CRP is also an independent risk factor for heart disease [1,6,11]. A positive relation was 
found between the periodontal level and the hs-CRP level [17]. PD therapy has improved 
biomarkers of systemic inflammation and even surrogate indicators of subclinical arterial disease 
[18] 
Based on the results of the research that has been done, there is 31% decrease in hs-CRP 
levels after treatment of scaling and root planing 31%, this can be used periodontal therapy intended 
to reduce the level of bacteria, especially P. gingivalis [6]. Statistical test results indicate a 
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significant difference between hs-CRP levels before treatment with hs-CRP levels after treatment. 
This is in accordance with previous research that periodontal therapy is associated with a decrease in 
hs-CRP levels [19]. 
In this study the number of samples was 30 people but there was one sample that was 
excluded from the study because the hs-CRP levels of the sample before treatment were too stretch 
of 124 mg/L, > 10.0 mg/L indicated the possibility of infection/acute inflammation. Chronic 
inflammation does not result in a very high increase in CRP concentrations, but rather within a low 
concentration range (<10 mg/L). Increased serum CRP levels are a marker of systemic 
inflammation, the concentration of CRP in the 1-10 mg/L range may indicate a risk for 
cardiovascular disease [10]. After treated with scaling and root planing to this sample hs-CRP level 
decrease to 12,09 mg/L. 
Serum IL-6 and CRP levels were reported to increase with age [20]. Increased levels of hs-
CRP are also reported in women because of the effects of hormonal changes [21]. Various studies 
have proven that CRP levels are closely related to obesity, that there is a positive correlation 
between hs-CRP and BMI [22]. In obesity, there is a chronic inflammatory condition of low levels 
especially in white adipose tissue. Macrophage accumulation is often found in white adipose tissue. 
Adipose tissue macrophages will produce several proinflammatory cytokines, such as TNF-α, 
interleukin-6, monocyte chemotactic protein, transforming growth factor β1, and procoagulant 
factors. Interleukin-6 will induce liver to produce C-reactive protein [22,23]. 
 
Conclusion 
There was a significant difference between hs-CRP levels before and after treatment. 
Lowering in hs-CRP levels after treatment of scaling and root planing may contribute to alleviate 
risk of coronary heart disease. 
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